In-patient Study With GSK716155 In Patients With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
This study is a placebo-controlled study in patients with Type 2 Diabetes Mellitus to assess
safety and tolerability parameters, the levels of GSK716155 in the bloodstream when it is
given at the same dose 7 days apart, and the impact this medication has on various substances
in the blood. Assessments include ECGs, vital signs, repeat blood sampling and monitoring of
any side effects.